
KBioBox: Advanced bioinformatics tech firm offering precise gene editing applications since 2013.
Founded in 2013 and headquartered in Worcester, Massachusetts, KBioBox is a bioinformatics technology company dedicated to advancing gene editing research. The company’s core mission is to eliminate research bottlenecks and empower scientific results through precise bioinformatic solutions. KBioBox offers applications for gene edit design, off-target analysis, and extended GUIDEseq analysis, leveraging their proprietary BioEngine software to provide fast and accurate bioinformatic searches. Their market focus includes academic researchers, biotechnology firms, and pharmaceutical companies.
KBioBox has attracted notable investors and bioinformatics experts who support its innovative approach to gene editing. The company’s patented technology has significantly impacted the field by enhancing the accuracy and speed of bioinformatic searches, thereby accelerating research timelines. Key achievements include the successful implementation of their software in various high-profile research projects, contributing to advancements in genetic engineering and therapeutic development. Overall, KBioBox has established itself as a vital player in the bioinformatics landscape, driving progress in gene editing technologies.

Bioinformatics
bioinfoinc.com

BioDatomics
biodatomics.com

eBioinformatics

InSyBio
insybio.gr

Amber Bio
amber.bio

GeneCentrix
genecentrix.com

BioTuring
bioturing.com

Karyosoft
karyosoft.com

Bionl
bionl.ai

Insightful Science

Bioinfoexperts
bioinfox.com

Watershed Informatics
watershed.bio

Intrepid Bioinformatics
intrepidbio.com

Golden Helix
goldenhelix.com

Navipoint Genomics
Companies similar to Kbiobox include Bioinformatics, BioDatomics, eBioinformatics and InSyBio.
Kbiobox was founded in 2013.
Kbiobox's headquarters is located in Worcester, MA, US.
Kbiobox's most recent funding round was for $100k (USD) in June 2015.
As of Jun 18, 2015, Kbiobox has raised a total of $100k (USD).
Kbiobox has 6 employees as of Feb 5, 2024.